Metastatic Colorectal Cancers Not Yet Recruiting Phase 1 / 2 Trials for Regorafenib (DB08896)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03657641Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal CancerTreatment
NCT04008511Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal CancerTreatment